论文部分内容阅读
最新研究数据显示,单剂A型肉毒杆菌毒素可快速、有效而安全地治疗仅次于神经原性逼尿肌超活性的尿失禁。在近期的美国泌尿协会(AuA)年会上公布的这项研究结果来自于一项包括59例需要定期清洁间隔期自插导管和口服抗胆碱能药物治疗失败的神经性尿失禁患者的多中心试验。瑞士苏黎士大学医院脊髓损伤中心神经病学系主任Brigitte Schurch博士在提供数据时对此解释说,插管期间发生的尿失禁在需要间歇清洁自插导管以排干膀胱的神经性患者
Recent data show that single-dose botulinum toxin type A can rapidly, effectively and safely treat urinary incontinence secondary to neurogenic detrusor hyperactivity. The findings, released at the recent annual meeting of the American Association of Urinary Tracts (AINA), come from a study of 59 patients with neurogenic urinary incontinence who failed routine catheterization and oral anticholinergic treatment at regular intervals Center test. Dr. Brigitte Schurch, Ph.D., director of the Department of Spinal Cord Injury Central Neurology at the University Hospital Zurich, Switzerland, explained in the data that urinary incontinence during intubation is required in neurological patients who need to intermittently clean their own cannula to drain the bladder